ANTI-INSULIN ANTIBODY - ANVISA Registration 10337680205

Access comprehensive regulatory information for ANTI-INSULIN ANTIBODY in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 10337680205 and manufactured by RSR LIMITED. The registration is held by GENESE PRODUTOS DIAGNOSTICOS LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including MEDIPAN, ORGENTEC DIAGNOSTIKA GMBH, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
10337680205
Registration Details
ANVISA Registration Number: 10337680205
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Device Details

INSULINA AB V3
Risk Class II

Registration Details

10337680205

25351077656201511

68384155000102

Company Information

RSR LIMITED
United Kingdom
PT: REINO UNIDO

Dates and Status

Apr 20, 2015

VIGENTE

09/18/2025 19:00:01